Table 1.
Clinical characteristics and follow-up of 31 cases of sclerosing adenosis involved by carcinoma in situ
| Case | Age (years) | D/L | Presentation | Treatment | Findings | Follow-up |
|---|---|---|---|---|---|---|
| 1 | 61 | L | C | SM | SA/LCIS | A&W 9 years |
| 2 | 61 | L | C | SM | SA/LCIS | A&W 9 years |
| 3 | 56 | L | C | NS | N/A | A&W 5 years |
| 4 | 54 | L | M | SM | FA, SA only | A&W 6 years |
| 5 | 53 | L | C | TM | SA/LCIS, ADH | No F/U |
| 6 | 36 | L | C, A | NS, T | N/A | A&W 6 years |
| 7 | 57 | L | C | NS | N/A | No F/U |
| 8 | 55 | L | C | NS, T | N/A | A&W 5 years |
| 9 | 55 | L | C | NS | N/A | NSCLC, no breast F/U |
| 10 | 54 | L | C | NS, T | N/A | A&W 6 years |
| 11 | 60 | L | C | NS | N/A | A&W 2 years |
| 12 | 43 | L | C | NS | N/A | A&W 1 year |
| 13 | 47 | L | E | TM | SA/LCIS | A&W 2 years |
| 14 | 48 | L | C | TM | LCIS | A&W 1 year |
| 15 | 57 | L | D | SM | SA/LCIS | A&W 1 year |
| 16 | 21 | L | M | NS | N/A | US F/U |
| 17 | 45 | L | C | TM | LCIS | A&W < 1 year |
| 18 | 51 | L | C | Pending | N/A | N/A |
| 19 | 65 | L | C | NS | N/A | A&W 6 mo. |
| 20 | 49 | D | D | TM | DCIS, LCIS, 1.8-mm focus of inv. Ca (pred. tubular type) | A&W 11 years |
| 21 | 66 | D | C, Di | SM | DCIS/CSL | A&W 4 years |
| 22 | 49 | D | C | TM | IDC, 3 cm with SA/DCIS | No F/U |
| 23 | 34 | D | C | TM | DCIS | No F/U |
| 24 | 72 | D | C | TM | DCIS | Deceased, small cell ca |
| 25 | 55 | D | M | SM | SA/DCIS | A&W 4 years |
| 26 | 52 | D | A | SM | SA/DCIS | A&W 2 years |
| 27 | 46 | D | C | UNK | UNK | UNK |
| 28 | 64 | D | C/D | SM | DCIS | A&W 1 year |
| 29 | 58 | D | M | UNK | UNK | UNK |
| 30 | 47 | D | M | SM | DCIS | Also IDC another site, same breast |
| 31 | 55 | D | M | SM | DCIS/CSL | A&W 2 years |
A asymmetry, D ductal, L lobular, Di distortion, SM segmental mastectomy, TM total mastectomy, NS no surgery, T tamoxifen, IDC invasive ductal carcinoma, UNK unknown, A&W alive and well, CSL complex sclerosing lesion, NSCLC non-small cell lung carcinoma